Willow vs Hers: Oral GLP-1 with tracking vs Wegovy from $149/mo

Quick verdict: Willow centers on an oral GLP-1 weight management program with structured progress tracking and follow-up, while Hers emphasizes FDA-approved brand-name Wegovy® from $149/mo and ongoing dose check-ins. Choose Willow for a telehealth-first program that stresses behavioral support; choose Hers for access to FDA-approved Wegovy and brand-name options.

Explore Willow’s program and tracking tools

Overview: Willow vs Hers at a glance

This comparison focuses on distinctive differences supported by the evidence: medication type and FDA status, price starting points, care and follow-up structure, program framing and features, and regulatory notes about compounded medications. Both require that treatment is available only when a licensed clinician determines it is medically appropriate.

1. Medication type and FDA status

Willow: Positions an oral GLP-1 program; the provider notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The documentation frames Willow as a telehealth-first weight management program emphasizing progress tracking and follow-up support.

Hers: Offers FDA-approved Wegovy® (brand-name semaglutide) and explicitly states it is not a compounded product. Hers also references other brand GLP-1s and clarifies Ozempic® is FDA approved for type 2 diabetes but may be prescribed off-label for weight loss at a clinician’s discretion. Hers highlights that Wegovy® and Zepbound® are FDA-approved for weight loss.

2. Pricing and starting points

Willow: Starting price captured as 299. No further verified shipping, fees, membership, or cancellation details were captured on the page evidence.

Hers: Lists Wegovy® pill from $149/mo and injectable options from $199/mo. Hers also notes pricing examples such as medication from $149/mo and that an active Hers Weight Loss Membership is required for medication, with membership fees referenced in captured content. The source states that price includes medication only, if prescribed, and that membership and medication are billed separately.

3. Care model and follow-up

Willow: Emphasizes a structured weight management journey with progress tracking tools, licensed telehealth team, and follow-up consultations. The long description frames Willow as converting GLP-1 efficacy into sustainable long-term outcomes through behavioral scaffolding and a simple digital workflow.

Hers: Highlights a personalized care team with ongoing dose check-ins and states no compounded medications. Hers points to doctor-trusted GLP-1s and name brand medication with personalized check-ins as core features.

4. Program framing and best-for recommendations

Willow: Best for users who want structured digital follow-up, according to the captured evidence. Pros include a simple digital workflow; a noted con is higher monthly entry pricing for some plans. Treatment is available only when a licensed clinician determines it is medically appropriate.

Hers: Best for people who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment, per the source. Pros include FDA-approved Wegovy®, personalized care team with dose check-ins, and an explicit no compounded medications position. Cons include higher starting price than some compounded competitors and no compounded or generic alternative offered.

See Hers options with Wegovy starting at $149/mo

5. Regulatory and safety notes

Both sources include regulatory notes: Willow states that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers repeats that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality, and emphasizes that certain brand products are FDA-approved for weight loss while others are approved for type 2 diabetes and may be used off-label.

Comparison table: Willow vs Hers

Conclusion: Willow vs Hers and final recommendation

Willow vs Hers comes down to program focus and medication status. Willow emphasizes an oral GLP-1 program layered with progress tracking and follow-up, framing treatment as a structured journey and noting that treatment is available only when a licensed clinician determines it is medically appropriate. Hers emphasizes access to FDA-approved Wegovy® from $149/mo, personalized dose check-ins, and an explicit no compounded medications policy.

Start Willow’s tracked weight management program

Learn more about Willow’s telehealth care and follow-up

Choose Willow if…

You want a telehealth-first, structured weight management journey that emphasizes progress tracking and follow-up consultations and are seeking a program framed around behavioral support. Treatment is available only when a licensed clinician determines it is medically appropriate.

Choose Hers if…

You prefer FDA-approved brand-name Wegovy® and a personalized care team with ongoing dose check-ins, and you will confirm eligibility, total cost, renewal terms and state availability before enrolling. Medication and membership terms are noted in Hers’ captured evidence.

Primary keyword: Willow vs Hers